Zacks Research Increases Earnings Estimates for Integer

Integer Holdings Co. (NYSE:ITGR - Free Report) - Investment analysts at Zacks Research upped their FY2024 earnings estimates for Integer in a research note issued to investors on Tuesday, January 7th. Zacks Research analyst D. Dey now forecasts that the medical equipment provider will earn $5.33 per share for the year, up from their previous forecast of $5.32. The consensus estimate for Integer's current full-year earnings is $5.33 per share. Zacks Research also issued estimates for Integer's Q1 2025 earnings at $1.32 EPS, Q4 2025 earnings at $1.67 EPS, Q2 2026 earnings at $1.55 EPS and Q4 2026 earnings at $1.76 EPS.

Other analysts have also recently issued reports about the company. KeyCorp raised their price target on Integer from $139.00 to $144.00 and gave the company an "overweight" rating in a report on Tuesday, October 15th. Benchmark increased their target price on shares of Integer from $130.00 to $140.00 and gave the company a "buy" rating in a report on Monday, October 21st. Truist Financial lifted their price target on shares of Integer from $147.00 to $163.00 and gave the company a "buy" rating in a research report on Wednesday, December 11th. Piper Sandler restated an "overweight" rating and issued a $140.00 price target (up previously from $125.00) on shares of Integer in a report on Friday, October 25th. Finally, Bank of America lifted their price objective on Integer from $135.00 to $145.00 and gave the stock a "buy" rating in a report on Tuesday, October 1st. One investment analyst has rated the stock with a hold rating and eight have issued a buy rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average price target of $145.44.

Integer Stock Performance

ITGR traded up $0.97 during trading on Thursday, reaching $133.13. The company's stock had a trading volume of 153,558 shares, compared to its average volume of 132,192. The company has a debt-to-equity ratio of 0.67, a quick ratio of 2.09 and a current ratio of 3.28. The company's fifty day moving average price is $135.73 and its 200-day moving average price is $127.72. Integer has a 52-week low of $94.56 and a 52-week high of $142.76. The company has a market capitalization of $4.47 billion, a price-to-earnings ratio of 41.09, a price-to-earnings-growth ratio of 1.99 and a beta of 1.12.

Integer (NYSE:ITGR - Get Free Report) last released its quarterly earnings results on Thursday, October 24th. The medical equipment provider reported $1.43 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.36 by $0.07. Integer had a return on equity of 11.63% and a net margin of 6.70%. The firm had revenue of $431.42 million for the quarter, compared to the consensus estimate of $440.59 million. During the same quarter last year, the business posted $1.27 EPS. The firm's quarterly revenue was up 8.7% compared to the same quarter last year.

Hedge Funds Weigh In On Integer

A number of institutional investors have recently modified their holdings of the company. Contravisory Investment Management Inc. increased its holdings in Integer by 55.9% in the 3rd quarter. Contravisory Investment Management Inc. now owns 223 shares of the medical equipment provider's stock valued at $29,000 after purchasing an additional 80 shares in the last quarter. HighTower Advisors LLC raised its stake in Integer by 0.8% during the third quarter. HighTower Advisors LLC now owns 12,041 shares of the medical equipment provider's stock valued at $1,579,000 after buying an additional 90 shares in the last quarter. Xponance Inc. raised its position in shares of Integer by 4.9% during the 2nd quarter. Xponance Inc. now owns 2,112 shares of the medical equipment provider's stock valued at $245,000 after acquiring an additional 99 shares in the last quarter. Azzad Asset Management Inc. ADV lifted its position in shares of Integer by 0.9% in the 3rd quarter. Azzad Asset Management Inc. ADV now owns 11,572 shares of the medical equipment provider's stock worth $1,504,000 after buying an additional 107 shares during the last quarter. Finally, Versant Capital Management Inc lifted its holdings in Integer by 98.4% in the fourth quarter. Versant Capital Management Inc now owns 369 shares of the medical equipment provider's stock worth $49,000 after acquiring an additional 183 shares during the last quarter. Institutional investors and hedge funds own 99.29% of the company's stock.

About Integer

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.